Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Samir Hussein joins Ladenburg Thalmann in TMT investment banking

Ladenburg Thalmann has announced the appointment of Samir Hussein as managing director, TMT investment banking, based in New York. Mr. Hussein brings more than two decades of investment banking experience advising...

January 28, 2025

Executive Moves

Biodexa names Dr. Gary A. Shangold as CMO

Biodexa Pharmaceuticals (NASDAQ:BDRX) has announced the appointment of Dr. Gary A. Shangold as chief medical officer (CMO), effective immediately. The company stated that Dr. Shangold brings extensive experience across...

January 22, 2025

Executive Moves

Terence Tan joins William Blair’s Biopharma Investment Banking Group

William Blair, a global investment firm, has announced the addition of Terence Tan as managing director in its healthcare investment banking team. In this role, Mr. Tan will focus on delivering comprehensive advisory...

January 14, 2025

Executive Moves

Piper Sandler adds John Kerins to healthcare investment banking team

Leading investment bank Piper Sandler has announced the appointment of John Kerins as a managing director on its healthcare investment banking team. In this role, he will serve pharma services clients from the firm’s...

January 14, 2025

Executive Moves

Dr. Elena Ratner joins Eterna’s BOD

Eterna Therapeutics (NASDAQ:ERNA) has announced the appointment of Elena Ratner, MD, MBA, to its board of directors. The company states that Dr. Ratner will spearhead the strategic direction of Eterna’s efforts to...

January 9, 2025

Executive Moves

Tonix appoints Gary Ainsworth as VP of market access

Tonix Pharmaceuticals (NASDAQ:TNXP) has announced the appointment of Gary Ainsworth as vice president of market access, effective immediately. Mr. Ainsworth brings extensive pharmaceutical and healthcare consultancy...

January 8, 2025

Executive Moves

Grown Rogue announces Andrew Marchington as CFO and corporate secretary

Grown Rogue (CSE:GRIN; OTC:GRUSF) has appointed Andrew Marchington as its chief financial officer (CFO) and corporate secretary, succeeding Ryan Kee effective January 1, 2025. Previously serving as senior vice president...

January 2, 2025

Executive Moves

Avalo names Jennifer Riley as CSO

Avalo Therapeutics (NASDAQ: AVTX) has announced the appointment of Jennifer Riley as chief strategy officer (CSO), a newly created role effective January 1, 2025. Ms. Riley will oversee corporate strategy, as well as...

January 2, 2025

Executive Moves

Karyopharm appoints Lori Macomber as EVP, CFO, and treasurer

Karyopharm Therapeutics (NASDAQ: KPTI) has announced the appointment of Lori Macomber as executive vice president (EVP), chief financial officer (CFO), and treasurer, effective January 3, 2025. Ms. Macomber, who will be...

January 2, 2025

Executive Moves

Veteran life science equity analyst Chad Messer joins Lake Street Capital Markets

Seasoned life science equity analyst, Chad Messer, Ph.D., has joined Lake Street Capital Markets as a managing director of equity research. Based in New York, Dr. Messer has over two decades of experience spanning...

January 2, 2025

Executive Moves

Applied names John H. Johnson as EC; Shoshana Shendelman steps down as CEO

Applied Therapeutics (NASDAQ:APLT) has announced leadership changes, naming John H. Johnson as executive chairman (EC) and Les Funtleyder, formally CFO, as interim CEO. Shoshana Shendelman, MD, has stepped down from her...

December 20, 2024

Executive Moves

Adicet appoints Julie Maltzman as CMO

Adicet Bio (NASDAQ:ACET) has appointed Julie Maltzman, MD, as chief medical officer (CMO), effective January 13, 2025. Adicet reports that Dr. Maltzman succeeds Dr. Francesco Galimi, who has completed his tenure with...

December 18, 2024

Executive Moves

Jeb Ledell joins KalVista as COO

KalVista Pharmaceuticals (NASDAQ:KALV) has announced that Jeb Ledell has been appointed as chief operating officer (COO). Mr. Ledell brings more than 20 years of leadership and operational excellence in the...

December 16, 2024

Executive Moves

Rockwell names Jesse Neri as CFO

Rockwell Medical (NASDAQ:RMTI) announced the promotion of Jesse Neri to chief financial officer (CFO). Mr. Neri, formally Rockwell’s senior vice president of finance, joined the company in 2023, bringing more than 25...

December 12, 2024

Executive Moves

Outlook’s CEO steps down; Lawrence Kenyon named interim CEO

Outlook Therapeutics (NASDAQ:OTLK) has appointed Lawrence Kenyon, EVP, CFO, and board member, as interim CEO, effective immediately. Russell Trenary has stepped down as the company’s president and CEO. Mr. Kenyon has...

December 4, 2024

Executive Moves

MOBILion launches proteomics advisory board

Closely-held MOBILion Systems announced the formation of a proteomics advisory board to provide strategic guidance as the company advances the development of its next-generation high-resolution mass spectrometry...

November 20, 2024

Executive Moves

MindMed names Gregg Pratt as chief regulatory and quality assurance officer

MindMed (NASDAQ:MNMD) has appointed Gregg Pratt, Ph.D., as chief regulatory and quality assurance officer. Dr. Pratt will oversee the company’s regulatory and quality functions, as well as its product registration...

November 18, 2024

Executive Moves

Opthea names Kathy Connell to BOD

Opthea (ASX/NASDAQ:OPT) announced the appointment of Kathy Connell to its board of directors as a non-executive director. Ms. Connell brings extensive business development expertise across pharmaceutical, vaccine...

November 15, 2024

Executive Moves

Lifecore appoints Thomas Guldager as VP operations, names Jackie Klecker as EVP quality

Lifecore Biomedical (NASDAQ:LFCR) has announced the appointments of Thomas Guldager as vice president of operations and Jackie Klecker as executive vice president of quality development services. Mr. Guldager brings...

November 4, 2024

Executive Moves

Dr. Makoto Kuro-o joins Klotho as scientific advisor

Klotho Neurosciences (NASDAQ:KLTO) has appointed Makoto Kuro-o, MD, Ph.D., to its scientific advisory board. Dr. Kuro-o, a pioneer in the discovery of the anti-aging Klotho (s-KL) gene, will support Klotho’s mission to...

October 23, 2024

Executive Moves

Tom Tamberrino joins Profound as new CCO ahead of TULSA reimbursement going into effect at the start of 2025

Profound Medical (NASDAQ:PROF; TSX:PRN) announced the appointment of Tom Tamberrino as chief commercial officer (CCO). Abbey Goodman, the current CCO, will now lead strategic partnerships and continue to report to CEO...

October 17, 2024

Executive Moves

Lake Street Captial Markets names Alex Nowak as director investment banking

Alex Nowak has joined Lake Street Capital Markets’ growing banking team as director of the healthcare investment banking practice. In his new role, Mr. Nowak will focus on expanding client relationships and supporting...

October 15, 2024

Samir Hussein joins Ladenburg Thalmann in TMT investment banking

Biodexa names Dr. Gary A. Shangold as CMO

Terence Tan joins William Blair’s Biopharma Investment Banking Group

Piper Sandler adds John Kerins to healthcare investment banking team

Dr. Elena Ratner joins Eterna’s BOD

Tonix appoints Gary Ainsworth as VP of market access

Grown Rogue announces Andrew Marchington as CFO and corporate secretary

Avalo names Jennifer Riley as CSO

Karyopharm appoints Lori Macomber as EVP, CFO, and treasurer

Veteran life science equity analyst Chad Messer joins Lake Street Capital Markets

Applied names John H. Johnson as EC; Shoshana Shendelman steps down as CEO

Adicet appoints Julie Maltzman as CMO

Jeb Ledell joins KalVista as COO

Rockwell names Jesse Neri as CFO

Outlook’s CEO steps down; Lawrence Kenyon named interim CEO

MOBILion launches proteomics advisory board

MindMed names Gregg Pratt as chief regulatory and quality assurance officer

Opthea names Kathy Connell to BOD

Lifecore appoints Thomas Guldager as VP operations, names Jackie Klecker as EVP quality

Dr. Makoto Kuro-o joins Klotho as scientific advisor

Tom Tamberrino joins Profound as new CCO ahead of TULSA reimbursement going into effect at the start of 2025

Lake Street Captial Markets names Alex Nowak as director investment banking

General

More